Coronavirus vaccines are on the way. Moreover, they will be available sooner than most public health experts had expected -- and more effective to boot. That's great news for airlines, which have been hit hard by the COVID-19 pandemic in 2020. However, one airline stock could be the biggest winner from the global vaccine rollout: Volaris (NYSE: VLRS) . Despite having already recovered all of its losses from earlier this year, this Mexican airline stock is primed for further gains, as it is poised to dominate the Mexican aviation recovery.
Since the beginning of November, the developers of three COVID-19 vaccine candidates have reported promising clinical trial results. Vaccine candidates developed by Moderna and a Pfizer -BioNTech partnership both reduced COVID-19 cases by 95% compared to placebo groups. A vaccine candidate developed by the University of Oxford and AstraZeneca is up to 90% effective, based on initial data.
Each of these vaccines -- and in all likelihood, several others -- will be available in huge quantities in 2021. This could essentially end the pandemic within a year. That in turn should make people comfortable traveling by air again, setting the stage for the global airline industry to recover gradually.
For further details see:
A Coronavirus Vaccine Could Send This Airline Stock Flying Even Higher